Nasdaq

Notch Therapeutics Appoints David Main as President and Chief Executive Officer to Advance the Company's Novel Gene-Edited, iPSC-Derived Immune Cell Therapeutics

TORONTO, July 20, 2020 /PRNewswire/ -- Notch Therapeutics Inc., a biotechnology company creating universally compatible, off-the-shelf T cell therapies for cancer and immune disorders from renewable ...
Business Wire

Orum Therapeutics Appoints David Main to Board of Directors

BOSTON & DAEJEON, South Korea--(BUSINESS WIRE)--Orum Therapeutics, a biotechnology company pioneering the development of tumor-directed targeted protein degraders to treat cancer, today announced the ...
The Business Journals

Economic development veteran David Main to retire (Video)

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. David Main, the only leader Hamilton County’s 35-year-old ...
The Wall Street Transcript

David Main – Inex Pharmaceutical Corporation (iex.to)

DAVID J. MAIN was appointed President and CEO of Inex Pharmaceutical Corporation on July 1, 1999 and since that time the company has advanced its lead product to a pivotal Phase II/III clinical trial ...